Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-007307
Filing Date
2015-01-28
Accepted
2015-01-28 21:50:35
Documents
2
Period of Report
2015-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5846
2 POA DOCUMENT poa.txt EX-24.3_557050 3142
  Complete submission text file 0001209191-15-007307.txt   10375
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Reporting) CIK: 0001291961 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36812 | Film No.: 15556622

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations